Hypertension, Vol 17, 909-916, Copyright © 1991 by American Heart Association
JP Tolins, PJ Shultz and L Raij
In addition to preserving the permselectivity of the vascular wall and
providing an antithrombogenic surface, the vascular endothelium contributes
importantly to the regulation of vasomotor tone. Indeed, the endothelium
participates in the conversion of angiotensin I to angiotensin II; the
enzymatic inactivation of several plasma constituents such as bradykinin,
norepinephrine, serotonin, and ADP; and the synthesis and release of
vasodilator substances such as prostacyclin and the recently discovered
endothelium-derived relaxing factor (EDRF). The diffusible EDRF released
from the endothelium is nitric oxide or a substance closely related to it
such as nitrosothiol. The endothelium also synthesizes and releases
vasoconstrictive factors, including products derived from arachidonic acid
metabolism and the recently discovered peptide endothelin. An increasing
body of evidence from experimental and clinical studies indicates that EDRF
and endothelium-derived contracting factors play an important role in
vascular physiology and pathology. It has become apparent that the balance
of these factors may be a major determinant of systemic and regional
hemodynamics. Moreover, through generally opposite effects on
growth-related vascular changes, contracting factors such as endothelin and
relaxing factors such as EDRF also may be important determinants of the
vascular response to injury in various disease states such as
atherosclerosis and hypertension. It is clear that the vascular endothelium
is a complex and dynamic organ. Understanding endothelium function in
normal physiology and disease states is of potential clinical importance
and should be the focus of future investigation.
ARTICLES
Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling. Update on humoral regulation of vascular tone
Department of Medicine, Veterans Administration Medical Center, Minneapolis, MN 55417.
This article has been cited by other articles:
![]() |
M. Booke, M. Westphal, F. Hinder, L. D. Traber, and D. L. Traber Cerebral Blood Flow Is Not Altered in Sheep with Pseudomonas aeruginosa Sepsis Treated with Norepinephrine or Nitric Oxide Synthase Inhibition Anesth. Analg., April 1, 2003; 96(4): 1122 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lambert, M. van den Berg, M. Steyn, J. A. Rauwerda, A. J.M. Donker, and C. D.A. Stehouwer Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries Cardiovasc Res, June 1, 1999; 42(3): 743 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T Goodwin, M. Amrani, A. J Marchbank, C. C Gray, J. Jayakumar, and M. H Yacoub Coronary vasoconstriction to endothelin-1 increases with age before and after ischaemia and reperfusion Cardiovasc Res, March 1, 1999; 41(3): 554 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. R. Mattsson, T. R. Kohler, S. M. Vergel, and A. W. Clowes Increased Blood Flow Induces Regression of Intimal Hyperplasia Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2245 - 2249. [Abstract] [Full Text] |
||||
![]() |
M. Booke, R. Waurick, H. Van Aken, H.-G. Bone, Andreas Meissner, T. Prien, and J. Meyer Effects of sympathetic nerve blockade on vasoconstrictive properties of nitric oxide synthase inhibition in sheep Cardiovasc Res, October 1, 1997; 36(1): 111 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lambert, M. Aarsen, A. J.M. Donker, and C. D.A. Stehouwer Endothelium-Dependent and -Independent Vasodilation of Large Arteries in Normoalbuminuric Insulin-Dependent Diabetes Mellitus Arterioscler Thromb Vasc Biol, May 1, 1996; 16(5): 705 - 711. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |